| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
27,638,000 |
| Market
Cap: |
2.07(M) |
| Last
Volume: |
2,358,324 |
Avg
Vol: |
2,351,803 |
| 52
Week Range: |
$0.075 - $0.08 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CytRx is a biopharmaceutical research and development company focusing on oncology and rare diseases. Co.'s focus is on the discovery, research and clinical development of anti-cancer drug candidates that employ linker technologies to improve the accumulation and release of cytotoxic anti-cancer agents at the tumor. The LADR™ (Linker Activated Drug Release) technology platform of Co.'s subsidiary, Centurion BioPharma Corporation, is a discovery engine combining Co.'s capability in linker chemistry and albumin biology to create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering agents directly to the tumor.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Simpson Jennifer K. |
Director |
– • – |
2021-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
| Brien Earl W |
Director |
– • – |
2020-08-14 |
4 |
OE |
$0.26 |
$39,000 |
D/D |
150,000 |
590,247 |
|
- |
|
| Kriegsman Steven A |
Chief Executive Officer |
• • – |
2020-08-07 |
4 |
D |
$0.67 |
$780,000 |
D/D |
(1,164,179) |
3,668,038 |
|
- |
|
| Kriegsman Steven A |
Chief Executive Officer |
• • – |
2020-08-07 |
4 |
OE |
$0.26 |
$780,000 |
D/D |
3,000,000 |
4,832,217 |
|
- |
|
| Ignarro Louis |
Director |
– • – |
2020-08-07 |
4 |
D |
$0.67 |
$182,000 |
D/D |
(271,642) |
600,785 |
|
- |
|
| Ignarro Louis |
Director |
– • – |
2020-08-07 |
4 |
OE |
$0.26 |
$182,000 |
D/D |
700,000 |
872,427 |
|
- |
|
| Caldwell Joel K |
Director |
– • – |
2020-08-07 |
4 |
D |
$0.67 |
$117,000 |
D/D |
(174,627) |
335,373 |
|
- |
|
| Caldwell Joel K |
Director |
– • – |
2020-08-07 |
4 |
OE |
$0.26 |
$117,000 |
D/D |
450,000 |
510,000 |
|
- |
|
| Kriegsman Steven A |
CEOChairman of the Board |
• • – |
2017-12-15 |
4 |
A |
$1.75 |
$678,295 |
D/D |
387,597 |
387,597 |
|
- |
|
| Chawla Shanta M.d. |
Senior VP-Drug DevelopmentOffi |
• – – |
2017-06-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,100 |
|
- |
|
| Kriegsman Steven A |
CEOChairman of the Board |
• • – |
2016-12-15 |
4 |
A |
$0.43 |
$1,000,000 |
D/D |
2,325,581 |
2,325,581 |
|
- |
|
| Brien Earl W |
Director |
– • – |
2016-12-02 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
61,484 |
|
- |
|
| Brien Earl W |
Director |
– • – |
2016-12-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
60,000 |
|
- |
|
| Selter Eric Jay |
Director |
– • – |
2015-04-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
27,144 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
|
